65: 2022 CMSC Annual Meeting Highlights

NeurologyLive® Mind Moments®

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a number of individuals who presented data and spoke at the Consortium of Multiple Sclerosis Centers Annual Meeting, on topics including women with multiple sclerosis, the importance of measuring cognition in MS, the characterization of relapse attacks in neuromyelitis optical spectrum disorder, the use of spinal cord atrophy as a biomarker of disease progression, the potential to save time reviewing complex patient histories, and more.
This episode is brought to you by Medical World News Second Opinion. Check out new episodes every Tuesday and Thursday only on medicalworldnews.com.
Those featured include (in order of appearance):

• Riley Bove, MD
• Blake E. Dewey, PhD
• Bruce Cree, MD, PhD, MAS
• John DeLuca, PhD
• Shuvro Roy, MD
• Tanuja Chitnis, MD

Episode Breakdown:

• 2:00 – Riley Bove, MD, on the conversations that women with multiple sclerosis have about disease-modifying therapies on social media platforms.
• 5:10 – Blake Dewey, PhD, on the efforts to improve the uptake in the use of spinal cord atrophy as a marker of disease progression.
• 8:45 – Bruce Cree, MD, PhD, MAS, on the latest data from the N-MOmemtum study in neuromyelitis optica spectrum disorder.
• 13:05 – John DeLuca, PhD, on the importance of measuring cognition longitudinally in patients with multiple sclerosis.
• 17:10 – Shuvro Roy, MD, on how the MS Smartform might be able to save physicians time in reviewing complex patient histories.
• 20:30 – Tanuja Chitnis, MD, on the use of foralumab in an older patient with nonactive secondary progressive multiple sclerosis.

Click here for more coverage of CMSC 2022.
Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.